Skip to main content

CorMedix Inc DEFA14A, filed Nov 16, 2026

CorMedix Inc. (CRMD)

CorMedix reported third-quarter revenue of $54.5 million, adjusted EBITDA of $3.1 million and $355 million cash. It maintained 2026 revenue guidance of $325 million to $345 million and narrowed adjusted EBITDA guidance to $130 million to $140 million. AI summary

DEFA14A 2026-11-16
View Original
Added on November 16, 2026